Edition:
United States

Novozymes A/S (NVZMY.PK)

NVZMY.PK on OTC Markets Group

38.26USD
27 Feb 2017
Change (% chg)

$0.17 (+0.46%)
Prev Close
$38.08
Open
$38.11
Day's High
$38.40
Day's Low
$38.11
Volume
37,978
Avg. Vol
64,247
52-wk High
$49.55
52-wk Low
$31.57

NVZMY.PK

Chart for NVZMY.PK

About

Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and... (more)

Overall

No Ratios Available.

Financials

  NVZMY.PK Industry Sector
P/E (TTM): -- 27.52 132.40
EPS (TTM): -- -- --
ROI: -- 11.96 9.16
ROE: -- 18.11 11.54

BRIEF-Novozymes President and CEO buys 27,700 shares at DKK 6,997,574

* President and CEO Peder Holk Nielsen buys 27,700 shares in Novozymes at 6,997,574 Danish crowns ($1 million) Source text for Eikon:

Jan 26 2017

BRIEF-Novozymes initiates stock buyback program

* Will buy back B shares worth up to 2 billion Danish crowns ($288.9 million) in total during remainder of 2017, corresponding to around 8.1 million B shares at current share price

Jan 24 2017

BRIEF-Novozymes EVP Anders Lund sells shares at about DKK 3.6 million

* Executive Vice President Anders Lund has sold 14,477 shares in Novozymes at about 3.6 million Danish crowns ($519,691)

Jan 23 2017

Novozymes cuts jobs, says U.S. policy, Monsanto deal pose risks

COPENHAGEN Enzymes maker Novozymes will cut 198 jobs and invest more in emerging markets, it said on Wednesday, adding it could time take to recapture past growth rates amid uncertainty over U.S. renewable energy policy and the takeover of a key partner.

Jan 18 2017

UPDATE 1-Novozymes cuts jobs, says U.S. policy, Monsanto deal pose risks

* Q4 earnings beat expectations, to buy back shares (Adds CEO comments)

Jan 18 2017

European shares boosted by company updates, though Pearson plummets

LONDON, Jan 18 European shares edged higher on Wednesday in early deals, helped by a slew of well-received company results from ASML, Novozymes and Burberry, though shares in Pearson slumped after its update.

Jan 18 2017

Novozymes cuts 198 jobs, to invest more in emerging markets

COPENHAGEN, Jan 18 Danish enzymes maker Novozymes said on Wednesday it would cut 198 jobs and allocate resources to high-growth opportunities in emerging markets, indicating it could take time to return to previous growth rates.

Jan 18 2017

BRIEF-Novozymes Q4 EBIT DKK 1.06 billion, beats expectations

* Q4 sales 3.71 billion Danish crowns (Reuters poll 3.60 billion crowns)

Jan 18 2017

European shares fall slightly led by Novozymes; Gucci owner soars

* IAG rises after British Airways pension deal (Adds details, updates prices)

Oct 26 2016

RPT-Novozymes Q3 EBIT below expectations, trims FY outlook

COPENHAGEN, Oct 26 Danish enzymes manufacturer Novozymes posted a lower-than-expected third quarter operating profit (EBIT) and trimmed its full-year outlook to the lower end of its previous range.

Oct 26 2016

More From Around the Web

Earnings vs. Estimates